NeuroHawk Hospital Monitor
Continuous monitoring of brain injury/hemorrhage in hospital settings
Key Facts
About Sense Diagnostics
Sense Neuro Diagnostics, founded in 2016 and based in San Francisco, is pioneering a novel diagnostic modality for time-sensitive brain injuries. Its investigational NeuroHawk™ device performs a 2.5-second scan of the cranial vault to identify hemorrhagic stroke, large vessel occlusion (LVO), and other brain bleeds, addressing critical gaps in pre-hospital triage and in-hospital monitoring. The company is currently conducting a pivotal FDA trial for its hospital monitor with a goal of clearance, while also developing earlier-stage field assessment versions for military and EMS use. Its technology aims to reduce disability and death by accelerating proper treatment pathways.
View full company profile